Development Level

Tbio 4 | 10,625
Tclin 4 | 602
Tchem 2 | 1,890

IMPC Term

abnormal behavior 1 | 226
abnormal femur morphology 1 | 14
preweaning lethality, incomple... 1 | 260

Disease

Cancer 7 | 2,346
ovarian cancer 7 | 8,484
Breast cancer 6 | 3,094
osteosarcoma 6 | 7,933
diabetes mellitus 5 | 1,663
interstitial cystitis 5 | 2,299
psoriasis 5 | 6,685
Arthritis 4 | 248
Kidney disease 4 | 396
Mammary Neoplasms 4 | 410
Vascular disease 4 | 281
glioblastoma 4 | 5,572
lung adenocarcinoma 4 | 2,713
lung cancer 4 | 4,466
non-small cell lung cancer 4 | 2,798
ulcerative colitis 4 | 2,087
Alzheimer's disease 3 | 644
Bipolar Disorder 3 | 266
Endometriosis 3 | 535
Inflammation 3 | 109
Obesity 3 | 616
Parkinson's disease 3 | 364
Prostatic Neoplasms 3 | 471
Schizophrenia 3 | 501
Toxic encephalopathy 3 | 131
breast carcinoma 3 | 1,614
cystic fibrosis 3 | 1,665
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung carcinoma 3 | 2,844
malignant mesothelioma 3 | 3,162
pancreatic cancer 3 | 2,300
posterior fossa group B ependymoma 3 | 1,530
primary Sjogren syndrome 3 | 789
tuberculosis 3 | 1,557
Adenocarcinoma 2 | 115
Adenoma 2 | 165
Adenomatous Polyposis Coli 2 | 10
Ankylosing spondylitis 2 | 138
Asthma 2 | 349
Asthma, Aspirin-Induced 2 | 13
Autistic Disorder 2 | 320
Bladder Neoplasm 2 | 109
Brain disease 2 | 83
Carcinoma 2 | 2,147
Cardiomegaly 2 | 66
Cardiomyopathies 2 | 90
Cerebrovascular disease 2 | 231
Cervical ripening procedure 2 | 9
Colitis 2 | 46
Colonic Neoplasms 2 | 126
Colorectal Neoplasms 2 | 217
Diabetes Mellitus, Experimental 2 | 106
Epilepsy 2 | 346
Fibrosis 2 | 40
Gastric ulcer 2 | 34
Gastrointestinal system disease 2 | 50
Gaucher disease type 3 2 | 76
Gout 2 | 93
Hydatidiform mole, benign 2 | 9
Hyperglycemia 2 | 120
Hyperplasia 2 | 26
Incomplete miscarriage 2 | 10
Induction of labor 2 | 10
Inflammatory bowel disease 2 | 142
Kidney Diseases 2 | 86
Liver carcinoma 2 | 217
Liver disease 2 | 219
Lung Neoplasms 2 | 171
Lung disease 2 | 132
Myocardial Infarction 2 | 126
Neoplasm Invasiveness 2 | 127
Neoplasm Metastasis 2 | 138
Neoplastic Cell Transformation 2 | 81
Osteoporosis 2 | 257
Pain 2 | 70
Papilloma 2 | 27
Patent ductus arteriosus 2 | 23
Precancerous Conditions 2 | 69
Pregnancy with abortive outcome 2 | 12
Reperfusion Injury 2 | 84
Rheumatoid Arthritis 2 | 1,160
Skin Neoplasms 2 | 49
Skin cancer 2 | 37
Squamous cell carcinoma 2 | 94
Status Epilepticus 2 | 85
acute myeloid leukemia 2 | 780
adrenocortical adenoma 2 | 134
adrenocortical carcinoma 2 | 1,427
aldosterone-producing adenoma 2 | 664
esophageal adenocarcinoma 2 | 737
group 3 medulloblastoma 2 | 2,254
hepatocellular carcinoma 2 | 532
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
invasive ductal carcinoma 2 | 2,950
juvenile dermatomyositis 2 | 1,189
medulloblastoma, large-cell 2 | 6,234
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031

Tissue

Blood and immune system 10 | 17,995
Cardiovascular System 10 | 17,958
Digestive Tract 10 | 18,473
Endocrine System 10 | 18,512
Female tissues 10 | 18,647
Liver and Pancreas 10 | 18,136
Male tissues 10 | 17,969
Nervous System 10 | 18,561
Respiratory system 10 | 17,484
Skin and soft tissues 10 | 18,115
Urinary Tract 10 | 18,444

Target Family

Non-IDG 3 | 11,971
Enzyme 2 | 4,146
GPCR 2 | 406
Kinase 2 | 634
Transcription Factor 1 | 1,400

Grant Application

1R01CA124615-01A2 10 | 10
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Prostaglandin G/H synthase 2 PTGS2 Tclin Enzyme -4.03668 12041.6 648
Keratin, type II cytoskeletal 5 KRT5 Tbio Non-IDG -2.82656 645.8 646
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74376 4837.7 851
Cytochrome c oxidase subunit 2 MT-CO2 Tchem Enzyme -2.93191 857.2 116
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Prostaglandin E2 receptor EP4 subtype PTGER4 Tclin GPCR -2.94537 922.9 216
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -3.97208 8801.0 1257
Prostaglandin E2 receptor EP2 subtype PTGER2 Tclin GPCR -1.20146 15.1 372
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137
Cyclic AMP-responsive element-binding protein 1 CREB1 Tbio Transcription Factor -3.58304 3764.1 1385